Subscribe
Sign In
Menu
Search
Financial Times
myFT
Search the
FT
Search
Search the
FT
Search
Close
Home
World
US
Companies
Tech
Markets
Climate
Opinion
Work & Careers
Life & Arts
HTSI
Sign In
Subscribe
Markets
Markets Data
Company Announcements
Financial Times
Close
International Edition
UK Edition
Search the
FT
Search
Top sections
Home
Show more World link
World
Israel-Hamas war
Global Economy
UK
US
China
Africa
Asia Pacific
Emerging Markets
Europe
War in Ukraine
Americas
Middle East & North Africa
Show more US link
US
US Economy
Investing in America
US Companies
US Politics & Policy
US Presidential Election 2024
Show more Companies link
Companies
Energy
Financials
Health
Industrials
Media
Professional Services
Retail & Consumer
Tech Sector
Telecoms
Transport
Show more Tech link
Tech
Artificial intelligence
Semiconductors
Cyber Security
Social Media
Show more Markets link
Markets
Alphaville
Markets Data
Cryptofinance
Capital Markets
Commodities
Currencies
Equities
Wealth Management
Moral Money
ETF Hub
Fund Management
Trading
Climate
Show more Opinion link
Opinion
Columnists
The FT View
The Big Read
Lex
Obituaries
Letters
Show more Work & Careers link
Work & Careers
Business School Rankings
Business Education
Europe's Start-Up Hubs
Entrepreneurship
Recruitment
Business Books
Business Travel
Working It
Show more Life & Arts link
Life & Arts
Arts
Books
Food & Drink
FT Magazine
House & Home
Style
Travel
FT Globetrotter
Show more Personal Finance link
Personal Finance
Property & Mortgages
Investments
Pensions
Tax
Banking & Savings
Advice & Comment
Next Act
HTSI
Special Reports
FT recommends
Lex
Alphaville
Lunch with the FT
FT Globetrotter
#techAsia
Moral Money
Visual and data journalism
Newsletters
Video
Podcasts
News feed
FT Live Events
FT Forums
Board Director Programme
myFT
Portfolio
FT Digital Edition
Crossword
Our Apps
Sign In
Company Announcements
Latest announcements
Apply
Cancel
Filter announcements by
Company
●
Index
View announcements for companies within...
Dow Jones Industrial Average
FTSE 100
FTSE 250
FTSE 350 ACT
FTSE All Share
FTSE Eurofirst 300
NASDAQ Composite
NYSE Composite
S&P 500
Headline contains
●
Release contains
Date range:
Last 24 hours
Last 7 days
Last 28 days
Last 12 months
Custom date
From
To
Sources:
GlobeNewswire
LSE Regulatory News Service
Business Wire press releases
Canada Wire press releases
PR Newswire press releases
EQS Newswire
Countries:
Filter by country
Austria
Belgium
Bosnia and Herzegovina
Croatia
Cyprus
Estonia
Czech Republic
Finland
Germany
Greece
Hungary
Iceland
Ireland
Italy
Latvia
Lithuania
Luxembourg
Macedonia
Malta
Netherlands
Norway
Poland
Portugal
Romania
Russia
Slovakia
Spain
Sweden
Switzerland
United States
United Kingdom
Turkey
Languages:
Filter by language
Danish
English
Estonian
Finnish
Icelandic
Latvian
Lithuanian
Swedish
Reset filters
Companies:
Index:
Headline contains:
Release contains:
Date range:
Sources:
Countries:
Languages:
Reset filters
Date and time
Company
Headline
Source
23 Apr 2024
Sasol Ltd
SASOF:PKC
SASOL LIMITED: PRODUCTION AND SALES METRICS FOR THE NINE MONTHS ENDED 31 MARCH 2024
PR Newswire
23 Apr 2024
EFT Solutions Holdings Ltd
8062:HKG
EFT Solutions Successfully Showcases in Money 20/20 Asia
EQS Newswire
23 Apr 2024
Amadeus Fire AG
AAD:BER
EQS-News: Quarterly statement three months 2024
EQS Newswire
23 Apr 2024
KKR & Co Inc
KR51:BER
KKR and Impilo Announce Strategic Partnership Together With Management in Rare Disease Platform Immedica Pharma
Business Wire
23 Apr 2024
Vertex Pharmaceuticals Inc
VX1:BER
VERTEX AND TREEFROG THERAPEUTICS ANNOUNCE LICENSING AGREEMENT AND COLLABORATION TO OPTIMIZE PRODUCTION OF VERTEX'S CELL THERAPIES FOR TYPE 1 DIABETES
PR Newswire
23 Apr 2024
Vertex Pharmaceuticals Inc
VX1:BER
VERTEX AND TREEFROG THERAPEUTICS ANNOUNCE LICENSING AGREEMENT AND COLLABORATION TO OPTIMIZE PRODUCTION OF VERTEX'S CELL THERAPIES FOR TYPE 1 DIABETES
PR Newswire
23 Apr 2024
Vertex Pharmaceuticals Inc
VX1:BER
VERTEX AND TREEFROG THERAPEUTICS ANNOUNCE LICENSING AGREEMENT AND COLLABORATION TO OPTIMIZE PRODUCTION OF VERTEX'S CELL THERAPIES FOR TYPE 1 DIABETES
Canada Newswire
23 Apr 2024
Tripadvisor Inc
TRIP:NSQ
TRIPADVISOR ANNOUNCES 2024 TRAVELERS' CHOICE HOTELS AWARD WINNERS: CHECK-IN TO THE BEST OF THE BEST PLACES TO STAY AROUND THE WORLD
PR Newswire
23 Apr 2024
RENAULT
RNL:BER
Renault Group: 2024 Q1 Group revenue at €11.7 billion, +5.9% at constant exchange rate; in the starting-blocks for the upcoming product offensive
GlobeNewswire
23 Apr 2024
eQ Oyj
EQV1V:HEX
eQ Plc’s interim report Q1 2024 – eQ’s profit fell
GlobeNewswire
23 Apr 2024
Novartis Pharma AG
NOVN:SWX
Novartis, au premier trimestre: croissance à deux chiffres du chiffre d’affaires et expansion de la marge core; hausse des prévisions pour 2024
GlobeNewswire
23 Apr 2024
Idorsia Pharmaceuticals Ltd
IDIA:SWX
Idorsia publishes an invitation to a bondholder meeting
GlobeNewswire
23 Apr 2024
Novartis Pharma AG
NOVN:SWX
Novartis erzielt im ersten Quartal ein zweistelliges Umsatzwachstum und steigert die Kerngewinnmarge; Prognose für das Geschäftsjahr 2024 erhöht
GlobeNewswire
23 Apr 2024
Idorsia Pharmaceuticals Ltd
IDIA:SWX
Idorsia publishes an invitation to a bondholder meeting
GlobeNewswire
23 Apr 2024
Sanofi - Aventis Groupe
AVET:PAR
Press Release: Rilzabrutinib LUNA 3 phase 3 study met primary endpoint in immune thrombocytopenia
GlobeNewswire
23 Apr 2024
Novartis Pharma AG
NOVN:SWX
Novartis delivers double-digit sales growth and core margin expansion in Q1; FY 2024 guidance raised
GlobeNewswire
23 Apr 2024
AS LHV Group
LHV1T:TLX
LHV Groupi 2024. aasta I kvartali auditeerimata majandustulemused
GlobeNewswire
23 Apr 2024
AS LHV Group
LHV1T:TLX
LHV Group unaudited financial results for Q1 2024
GlobeNewswire
RNS announcements are delayed by up to an hour.
Fewer results
1
2
3
...
498
499
500
More results